Candriam S.C.A. Ionis Pharmaceuticals Inc Transaction History

Candriam S.C.A.

$15.6 Billion
Q1 2025

A detailed history of Candriam S.C.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Candriam S.C.A. holds 993,704 shares of IONS stock, worth $35 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

993,704

Previous 849,824 16.93%

Holding current value

$35 Million

Previous $29.7 Million 0.91%

% of portfolio

0.19%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$30.17 - $34.97 $4.34 Million - $5.03 Million	143,880 Added 16.93%	993,704 $30 Million
Q4 2024 Feb 06, 2025	SELL	$33.73 - $40.36 $3.32 Million - $3.97 Million	-98,442 Reduced 10.38%	849,824 $29.7 Million
Q2 2024 Aug 05, 2024	BUY	$36.45 - $47.7 $1.33 Million - $1.73 Million	36,369 Added 3.99%	948,266 $45.2 Million
Q1 2024 May 03, 2024	BUY	$42.03 - $53.55 $11.9 Million - $15.1 Million	282,830 Added 44.96%	911,897 $39.5 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $3.47 Million - $4.13 Million	80,000 Added 14.57%	629,067 $31.8 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $962,500 - $1.18 Million	25,000 Added 4.77%	549,067 $24.9 Million
Q2 2023 Aug 08, 2023	BUY	$34.73 - $43.33 $2.74 Million - $3.42 Million	78,870 Added 17.72%	524,067 $21.5 Million
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $688,490 - $844,723	-20,503 Reduced 4.4%	445,197 $15.9 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $532,634 - $667,515	14,349 Added 3.18%	465,700 $17.6 Million
Q3 2022 Nov 10, 2022	SELL	$36.54 - $48.66 $4.36 Million - $5.81 Million	-119,341 Reduced 20.91%	451,351 $20 Million
Q2 2022 Aug 03, 2022	BUY	$31.71 - $43.0 $2.26 Million - $3.06 Million	71,145 Added 14.24%	570,692 $21.1 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $13.1 Million - $16.2 Million	-437,088 Reduced 46.67%	499,547 $18.5 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $35.1 $5.39 Million - $7.38 Million	210,276 Added 28.95%	936,635 $28.5 Million
Q3 2021 Nov 09, 2021	BUY	$33.54 - $40.55 $5.83 Million - $7.05 Million	173,793 Added 31.45%	726,359 $24.4 Million
Q2 2021 Jul 20, 2021	BUY	$34.54 - $47.25 $10.6 Million - $14.4 Million	305,612 Added 123.75%	552,566 $22 Million
Q4 2020 Jan 22, 2021	SELL	$45.3 - $60.27 $305,593 - $406,581	-6,746 Reduced 2.66%	246,954 $14 Million
Q2 2020 Jul 23, 2020	SELL	$46.85 - $61.05 $374,800 - $488,400	-8,000 Reduced 3.06%	253,700 $15 Million
Q4 2019 Jan 21, 2020	SELL	$53.85 - $65.27 $1.7 Million - $2.06 Million	-31,500 Reduced 10.74%	261,700 $16,000
Q2 2019 Aug 01, 2019	SELL	$62.09 - $86.14 $6.21 Million - $8.61 Million	-100,000 Reduced 25.43%	293,200 $18.8 Million
Q1 2019 May 02, 2019	BUY	$52.92 - $81.17 $7.62 Million - $11.7 Million	144,000 Added 57.78%	393,200 $31.9 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $2.13 Million - $2.92 Million	49,000 Added 24.48%	249,200 $13.5 Million
Q3 2018 Nov 07, 2018	BUY	$42.88 - $53.7 $1.9 Million - $2.38 Million	44,400 Added 28.5%	200,200 $10.3 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $559,314 - $699,660	13,800 Added 9.72%	155,800 $6.49 Million
Q4 2017 Feb 07, 2018	SELL	$50.3 - $64.39 $50,300 - $64,390	-1,000 Reduced 0.7%	142,000 $7.14 Million
Q3 2017 Nov 03, 2017	BUY	$45.56 - $59.57 $6.52 Million - $8.52 Million	143,000	143,000 $7.25 Million

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account